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Objectives: Numerous studies show increased prevalence of MDR bacteria amongst asylum seekers, but data
on the molecular profiles of such strains are limited. We aimed to evaluate the molecular profiles of ESBL-
producing Escherichia coli (ESBL-E. coli) strains isolated from asylum seekers and investigate their phylogenetic
relatedness.
Methods: WGS data of ESBL-E. coli isolates from asylum seekers, retrieved from 1 January to 31 December 2016,
were analysed to assess MLST STs, fim types, phylogroups and resistance genes. Fifty-two ESBL-E. coli isolates
from the Dutch–German border region were used for genome comparison purposes as a control group.
Results: Among 112 ESBL-E. coli isolates from asylum seekers, originating mostly from Syria (n = 40) and Iraq
(n = 15), the majority belonged to ST131 (21.4%) and ST10 (17.0%). The predominant gene for b-lactam resist-
ance was blaCTX-M-15 (67.9%), followed by the often co-detected blaTEM-1B (39.3%). No mcr or carbapenemase
genes were detected. The majority of the strains belonged to phylogroups B2 (38.4%) and A (32.1%), carrying
fimH27 (25%) and fimH30 (19.6%). A core genome MLST minimum spanning tree did not reveal clusters contain-
ing strains from the asylum seekers and the control group. Five clusters were formed within the asylum seeker
group, by strains isolated from people originating from different countries.
Conclusions: The most frequently isolated clones in this study were isolated on a regular basis within the Dutch
population before the increase in the asylum seeker population. No mcr- or carbapenemase-producing clones were
detected among the asylum seeker population. Minor clustering was observed amongst the asylum seeker strains.
Introduction
Increased numbers of refugees and asylum seekers have entered
Europe during the last decade. At the end of 2018, the United
Nations High Commissioner for Refugees reported nearly 6.5 million
refugees and migrants residing in Europe.1 According to the
Immigration and Naturalization Service of the Ministry of Justice and
Security, 196 519 asylum seekers entered the Netherlands from
January 2013 to December 2018. The main countries of origin in-
clude the Syrian Arab Republic, Afghanistan, Iraq, Iran and Eritrea.2
This increase in displaced populations has public health implica-
tions. The health needs of refugees and asylum seekers require
VC The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
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coordinated efforts from public health institutions. Medical care of
refugees and asylum seekers can be challenging for public health
systems and hospitals.3 Although data on the epidemiology of
MDR organisms (MDROs) in most of the countries of origin are lim-
ited, studies have shown an increased MDRO prevalence amongst
refugees and asylum seekers. A recently published systematic re-
view and meta-analysis on antimicrobial resistance among
migrants in Europe showed a pooled prevalence of any detected
antimicrobial resistance carriage or infection of 25.4% (95% CI
19.1%–31.8%). The pooled prevalence of MDR Gram-negative bac-
teria was 27.2% (95% CI 17.6%–36.8%).4
The need for adequate and timely MDRO detection and, subse-
quently, the implementation of infection prevention measures
regarding refugee inpatients is imperative. WGS has proved to be a
valuable tool for microbial analysis on a molecular level and for
MDRO outbreak investigation. During the last decade, WGS has
been increasingly integrated in microbiology laboratories as part of
the daily routine diagnostics, as it became easier, faster and
cheaper to use.5 This technique combined with bioinformatics
tools can provide, in less than 48 h, an abundance of valuable infor-
mation regarding MDROs, including detection, identification, gen-
etic resistance profile, genotype and epidemiological typing.
Further analysis of the data can also determine genetic and phylo-
genetic relatedness amongst strains, revealing clustering and aid-
ing outbreak investigation.6,7
The main mechanism of resistance to b-lactams in Escherichia
coli strains is production of ESBLs, a group of enzymes mainly
encoded by CTX-M, TEM and SHV variants.8 During the past decade,
blaCTX-M genes have been increasingly detected in Gram-negative
bacteria, including E. coli, worldwide, leading to a ‘CTX-M pandem-
ic’ situation.9 This rapid spread of certain CTX-M-producing E. coli
lineages carries with it difficulties in typing. Conventional typing
methods, such as PFGE and MLST, do not have the discriminatory
power to identify clusters of dissemination. Even next-generation
sequencing (‘NGS’)-based typing, which has higher discriminatory
power, does not always provide conclusive proof of dissemination
and should always be interpreted in combination with epidemio-
logical data. Additional methods, such as typing of fimH genes, are
useful to subtype certain lineages.10 In addition, sequences of epi-
demiologically unrelated isolates, so-called context isolates,
should be added to the analysis to provide insight into the genetic
background of the bacterial population.11
In this study, we evaluated the molecular profiles, including
STs, fim types, phylogroups and resistomes, of ESBL-producing
E. coli (ESBL-E. coli) strains isolated from hospitalized asylum
seekers in 2016. We compared the molecular epidemiology of the
isolates from the refugees with that of a collection of ESBL-E. coli
strains from the Dutch–German border region, from hospitalized
patients and a community population in 2012, before the number
of refugees started to increase.
Materials and methods
Study design
When entering the Netherlands, all asylum seekers are appointed to an
asylum seeker centre (ASC) and are registered under the ASC’s address.
Asylum seekers included in the study were identified by the ASC address at
which they resided. Data on patient characteristics were retrospectively col-
lected from the Certe laboratory system. Study material included screening
samples for MDRO carriage before admission (throat, rectum and nose) and
clinical samples (e.g. blood, wounds and urogenital) from asylum seekers.
All of these samples were obtained as part of standard care.
Study population
We included asylum seekers, hospitalized in the northern part of the
Netherlands from 1 January to 31 December 2016, who tested positive for
ESBL-E. coli strains. Demographic data, such as age, sex and country of ori-
gin, were collected from the laboratory system and the healthcare system
for asylum seekers. All ESBL-E. coli strains isolated from the study popula-
tion were included in the group of asylum seeker strains. Duplicate strains
with the same molecular, phenotypic and genotypic profile that were from
the same asylum seeker were excluded.
Bacterial identification and antimicrobial resistance
mechanism detection
ESBL-E. coli strains from asylum seekers were obtained in the Certe labora-
tory. This laboratory performs routine microbiological analyses for primary
and secondary medical care in the north-east of the Netherlands, including
the ASC population in this part of the country. Screening and clinical sam-
ples were cultured in a variety of selective (solid) media used for MDRO de-
tection, including MacConkey agar with 0.5 mg/L ciprofloxacin and 2 mg/L
gentamicin (Mediaproducts BV, Groningen, The Netherlands), ChromID
ESBL agar and ChromID Carbapenemase agar (both from bioMérieux,
Marcy-l’Étoile, France). The presence of ESBL was confirmed with cefotax-
ime/clavulanate, ceftazidime/clavulanate and cefepime/clavulanate Etests
(bioMérieux). Possible carbapenemase-producing Enterobacterales (CPE)
were confirmed by CIM test and PCR (Check-Direct CPE assay, Check-Points,
Wageningen, The Netherlands) and typed by the national reference net-
work for CPE at the RIVM (National Institute for Public Health), as part of
standard care.
Antimicrobial phenotype detection
Susceptibility to amikacin, amoxicillin/clavulanic acid, ampicillin/sulbactam,
cefepime, cefotaxime, ceftazidime, ciprofloxacin, colistin, ertapenem, fos-
fomycin, gentamicin, imipenem, levofloxacin, meropenem, nitrofurantoin,
piperacillin/tazobactam, tigecycline and trimethoprim/sulfamethoxazole
was determined using Vitek 2 (bioMérieux). EUCAST guidelines were used
for interpretation of MICs.
Control group isolates
The control isolate collection consisted of 41 ESBL-E. coli from hospitalized
patients and people in the community in the Netherlands and 11 ESBL-
E. coli strains from hospitalized patients in Germany.12 The isolates were
collected in 2012 and were used as context isolates in the genomic com-
parisons. All strains included in the control group were analysed using the
same workflow as the asylum seeker group strains.
DNA isolation
A total of 112 frozen ESBL-E. coli strains isolated from unique asylum
seekers were recultured and incubated for 24 h at 37C. DNA was extracted
using the DNeasy UltraClean Microbial Kit (MoBio Laboratories, Carlsbad, CA,
USA), according to the manufacturer’s instructions. A 5 lL aliquot of
each isolate was suspended with 300 lL of PowerBead solution. DNA purity
was measured using a NanoDrop 2000 C spectrophotometer (Thermo
Fisher, Waltham, MA, USA). DNA concentration was measured with a
Qubit 2.0 fluorometer, using the double-stranded DNA BR Assay Kit (Life
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WGS
Prior to library preparation, isolated DNA was diluted to a concentration of
0.2 ng/lL. DNA library preparation was performed with the Nextera XT v.01
(Illumina Inc., San Diego, CA, USA) kit using 5 lL of diluted DNA according to
the manufacturer’s instructions. Libraries were sequenced on an MiSeq se-
quencer (Illumina Inc.) aiming to generate 250 bp paired-end reads.
Quality check and WGS data analysis
Trimming and de novo assembly was performed using CLC Genomics
Workbench v.10.1.2 (QIAGEN, Hilden, Germany). A minimum Phred score
(Qscore) of 30 was used. Six parameters were checked for assembly quality:
number of contigs <1000, N50 > 15 000, maximum contig length >50 000,
percentage of reads used for the assembly >90%, coverage >30% and per-
centage of the expected genome size >90% to <115%.
The assembled genomes were uploaded to SeqSphere v.5.5.1 (Ridom
GmbH, Münster, Germany) for investigation of phylogenetic relatedness.
A minimum spanning tree based on allelic mismatch between the isolates
was designed. A maximum of 10 allelic differences was considered as clo-
nal clustering.
SNP-based Neighbor–Joining (NJ) trees were constructed based on the
genome sequences using Ridom SeqSphere! version 5.1.0 (Münster,
Germany) with default settings. The genomes were analysed using an ad
hoc E. coli scheme based on 2764 targets, including 242 851 bp.
Assembled genomes were uploaded to the web tools ResFinder 3.1 to
identify acquired resistance genes13 and FimTyper 1.0 to determine fim
type.10 Phylogroups were determined via the EzClermont web app and
command-line tool.14,15
Sequences are publicly available at the ENA database (study accession
number PRJEB36686).
Statistical analysis
Data were collected in and analysed with SPSS (version 2.23). Descriptive
statistics were used for the general characteristics of the study population.
Ethics
This study was evaluated by the Ethics Committee and approval was
waived in accordance with Dutch legislation owing to its retrospective na-
ture (University Medical Centre Groningen, METc number 2016/516). No
written informed consent was obtained from patients for the use of retro-
spective data. Patient information was anonymized and de-identified prior
to analysis.
Results
General characteristics of the study population
We evaluated single ESBL-E. coli isolates from 112 asylum seekers.
General characteristics of the study population and the included
samples are described in Table 1.
Routinely measured resistance
Antimicrobial susceptibility of the strains to different antibiotic
agents, routinely tested in the Certe laboratory, is described in
Table S1 (available as Supplementary data at JAC Online).
All of the isolates were resistant to penicillins, cephalosporins
and combinations of penicillins and b-lactamase inhibitors. Also,
56.3% of the isolates were resistant to trimethoprim/sulfameth-
oxazole. Resistance to ciprofloxacin was observed in 31.3% of the
isolates. Regarding aminoglycosides, 27.7% and 33.0% of the
isolates were resistant to gentamicin and tobramycin, respectively.
No isolate was resistant to meropenem or imipenem. All isolates
were susceptible to fosfomycin and colistin.
ST and genotypic profile
The most frequent ST of the asylum seeker isolates was ST131
(21.4%), followed by ST10 (17.0%), ST38 (8.0%) and ST69 (8.9%).
Among the control group isolates, the most frequent ST was ST38
(15.4%), followed by ST10 and ST131 (both 11.5%) and ST58
(7.7%). Table 2 shows the STs of the asylum seeker isolates and
the blaCTX-M resistance genes carried by the isolates for each ST.
The distribution of blaCTX-M resistance genes harboured by the
isolates from asylum seekers and the control group can be seen in
Figure 1.
The most frequently observed CTX-M gene for b-lactam resist-
ance was blaCTX-M-15 for both groups, followed by blaCTX-M-27 for the
asylum seekers and blaCTX-M-1 for the control group. Other, non-
CTX-M b-lactam resistance genes detected in the asylum seeker
isolates were blaTEM-1B (n = 44, 39.3%), blaOXA-1 (n = 11, 9.8%),
blaSHV-12 (n = 2), blaTEM-33 (n = 2), blaDHA-1 (n = 2), blaTEM-1C (n = 1)
and blaCMY-60 (n = 1).
All of the asylum seeker isolates carried resistance genes
related to more than one antibiotic group, including aminoglyco-
sides, fluoroquinolones, sulphonamides and trimethoprim.
Regarding aminoglycoside resistance, 44 isolates harboured strA,
43 harboured strB, 42 harboured addA5 and 21 harboured acc(3)-
IId. The main genes carried by the isolates that encoded quinolone
resistance were qnrS1 (n = 26) and aac(60)Ib-cr (n = 10). For sul-
phonamide resistance, 48 isolates carried sul1 and 40 isolates car-
ried sul2. Lastly, the main trimethoprim resistance genes detected
Table 1. General characteristics of the study population and the
included samples; N = 112
Female, n (%) 75 (67)
Age (years), median (IQR) 28.0 (20.4–36.1)
Number of days in the Netherlands, median (IQR) 192 (77–347)






other from Europe 6 (5.4)
other from Eastern Europe/Russia 4 (3.6)
other from Asia 8 (7.1)
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were dfrA17 (n = 44) and dfrA14 (n = 14). Of note, no mcr and car-
bapenemase genes were detected.
Phylogroup and fim type
Asylum seeker isolates belonged primarily to phylogroups B2
(n = 43, 38.4%) and A (n = 36, 32.1%). The remaining isolates
belonged to phylogroups D (n = 24, 21.4%), B1 (n = 6, 5.4%) and F
(n = 3, 2.7%).
Subtyping of fimH alleles of isolates from asylum seekers
showed that fimH27 was the most frequent type (n = 28, 25%), fol-
lowed by fimH30 (n = 22, 19.6%) and fimH5 (n = 6, 5.4%). Thirteen
isolates (11.6%) did not carry any fim gene. The remaining isolates
carried a wide variety of different fim genes. Of note, 19 out of the
24 isolates that belonged to ST131 carried fimH30 and 8 out of the
19 isolates that belonged to ST10 carried fimH27.
Analysis of the core genome MLST (cgMLST) NJ tree, including
asylum seeker and control group isolates, is shown in Figure 2.
Furthermore, the cgMLST NJ tree is shown in Figure S1 in rectangu-
lar form, including metadata, such as country of origin of the asy-
lum seekers, isolate ST and isolate phylogroup (given in the
columns next to the tree).
Phylogenetic relatedness and cluster analysis
A minimum spanning tree of the asylum seeker and control group
isolates can be seen in Figure S2. The observed allelic distance
ranged from 0 to 2371 alleles.
Cluster analysis revealed five clusters within the asylum seeker
group isolates (Figure S2). Cluster 1 consisted of six isolates belong-
ing to ST69, phylogroup D, subtype fimH27 and carrying blaCTX-M-15
(Figure 2). Two of the isolates were from asylum seekers originat-
ing from Syria and the remaining four were from asylum seekers
originating from Palestine, Afghanistan, Iraq and Yugoslavia. The
isolates from the Syrian and Iraqi asylum seekers were from rectal
and skin samples, cultured a day apart, respectively, and the iso-
lates from the Palestinian and Afghan asylum seekers came from
sputum and urine samples, respectively, cultured 17 days apart.
Cluster 2 was formed by five isolates belonging to ST10, phy-
logroup A, subtype fimH27 and carrying blaCTX-M-15 (Figure 2). All
isolates were obtained from asylum seekers originating from dif-
ferent countries, namely Syria, Iraq, Eritrea, Turkey and Benin. The
isolates from the Syrian and Iraqi asylum seekers were from rectal
samples, cultured 4 days apart. Cluster 3 consisted of four isolates
belonging to ST12, phylogroup B2, no fim subtype and carrying
blaCTX-M-15 (Figure 2). Two of the strains were isolated from Syrian
asylum seekers, one from a Mongolian asylum seeker and one
from an Afghan asylum seeker. One of the isolates that was from a
Syrian asylum seeker and the isolate that was from an Afghan asy-
lum seeker were from rectal samples, cultured a week apart.
Cluster 4 included two isolates belonging to ST1193, phylogroup
B2, subtype fimH64 and carrying blaCTX-M-15 (Figure 2). One was iso-
lated from a Syrian asylum seeker and the other from an Iranian;
Table 2. STs of the asylum seeker isolates and the blaCTX-M resistance




blaCTX-M resistance gene, n (%)
blaCTX-M-15 blaCTX-M-27 blaCTX-M-3 blaCTX-M-14 blaCTX-M-14b
ST131 24 (21.4) 12 (50.0) 7 (29.2) 1 (4.2) 0 (0) 0 (0)
ST10 19 (17.0) 16 (84.2) 0 (0) 2 (10.5) 1 (5.3) 0 (0)
ST69 10 (8.9) 8 (80) 0 (0) 1 (10) 0 (0) 0 (0)
ST38 9 (8.0) 1 (11.1) 1 (11.1) 0 (0) 1 (11.1) 3 (33.3)
ST12 7 (6.3) 7 (100.0) 0 (0) 0 (0) 0 (0) 0 (0)
ST120 4 (3.6) 3 (75.0) 0 (0) 0 (0) 0 (0) 0 (0)
ST93 4 (3.6) 4 (100.0) 0 (0) 0 (0) 0 (0) 0 (0)
ST1193 3 (2.7) 2 (66.7) 0 (0) 0 (0) 0 (0) 0 (0)
ST73 3 (2.7) 2 (66.7) 0 (0) 0 (0) 0 (0) 0 (0)
ST648 2 (1.8) 2 (100.0) 0 (0) 0 (0) 0 (0) 0 (0)
ST3877 2 (1.8) 2 (100.0) 0 (0) 0 (0) 0 (0) 0 (0)
ST58 2 (1.8) 2 (100.0) 0 (0) 0 (0) 0 (0) 0 (0)
























Figure 1. Distribution of the most frequently detected blaCTX-M genes among the asylum seeker and control group isolates. This figure appears in col-
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Figure 2. cgMLST Neighbor–Joining tree, including asylum seeker and control group isolates. Genomes were analysed using an ad hoc E. coli
scheme based on 2764 targets, including 24 2851 bp. Control group isolates were from health institutions near the Dutch–German border region.
Isolates that formed clusters in further phylogenetic analysis are indicated in dark pink. This figure appears in colour in the online version of JAC
and in black and white in the print version of JAC.
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they were isolated from urine and rectal samples, respectively, cul-
tured 7 months apart. Cluster 5 consisted of two isolates belonging
to ST120, phylogroup A, subtype fimH237 and carrying blaCTX-M-15
(Figure 2). The two isolates were from a Syrian asylum seeker and
an Eritrean asylum seeker; they were isolated from rectal samples,
cultured 10 days apart. No clusters contained isolates belonging to
both asylum seekers and control group isolates.
Discussion
A total of 112 ESBL-E. coli strains isolated from asylum seekers
were analysed using WGS in order to investigate their phylogenetic
relatedness and possible transmission within the asylum seeker
population in the northern part of the Netherlands. The asylum
seeker study population originated mainly from Syria and had
been residing in the Netherlands for a median of 192 days.
All isolates were phenotypically resistant to b-lactams and
exhibited various resistance profiles, with all of them being resist-
ant to at least one more antibiotic group, such as aminoglycosides,
quinolones and sulphonamides. The genes that encode resistance
to these antibiotic agents are often located on plasmids that can
co-harbour different resistance genes and can be horizontally
transferred amongst Enterobacterales, such as E. coli, rendering
the strains MDR.16
The majority of the isolates belonged to ST131 and ST10, and
harboured a blaCTX-M-15 gene. This is in accordance with the epi-
demiological profile of the high-risk ST131 blaCTX-M-15 clone. ST131
blaCTX-M-15 is currently globally disseminated and is identified as
the most widespread CTX-M ESBL enzyme worldwide.17,18 The
Netherlands has also been affected by the ST131 blaCTX-M-15 clone.
In a recently published study conducted in Dutch hospitals, be-
tween 2014 and 2016, the dominant clone found among ESBL-
E. coli blood isolates was ST131 carrying blaCTX-M-15.
19
Furthermore, in a study conducted in the Netherlands in 2016, the
clone was isolated among community-associated and hospital-
ized patients,20 indicating that the clone existed in both the
community and hospitals in the Netherlands before the number of
refugees started to increase in 2015 and 2016.
The majority of the study isolates harboured blaCTX-M-15, regard-
less of the ST to which they belonged. Even though strains carrying
blaCTX-M-15 have been reported all over Europe, strains carrying this
gene are isolated at a higher rate in Middle Eastern, Asian and
African regions.21 Furthermore, epidemiological data on the distri-
bution of such strains indicate that African and Asian regions could
serve as a reservoir and facilitate global dissemination.22 A
German study that investigated the antibiotic resistomes of refu-
gees reported high prevalence rates for b-lactamase genes: main-
ly blaTEM, blaCTX-M group 1 and blaSHV.
23 Another German study
reported high detection of blaCTX-M group 1 genes, followed by
blaTEM and blaSHV, among ESBL-producing Enterobacteriaceae iso-
lates from Libyan and Syrian patients.24 Furthermore, a study per-
formed in Saudi Arabia showed a prevalence of blaCTX-M-15 or
blaCTX-M-14 of 60% among ST131 uropathogenic E. coli strains.
25 In
addition, an Iranian study, published in 2017, demonstrated a high
prevalence of ST131 blaCTX-M-15 amongst clinical E. coli strains.
26 A
high prevalence of strains carrying these genes amongst asylum
seekers from Iran, Syria and Afghanistan was also documented in
our study.
Despite the fact that some clustering among the isolates from
the asylum seekers was observed, no clear pattern of transmission
was documented. Isolates that exhibited close phylogenetic re-
latedness formed five clusters. As expected, isolates within each
cluster exhibited identical genetic characteristics, such as ST, phy-
logroup and fim type. However, isolates included within each clus-
ter did not show a clear epidemiological link, since they were
isolated from asylum seekers mostly originating from different
countries. Furthermore, even though certain isolates in clusters 1,
2, 3 and 5 were isolated within 10 days or less, clear epidemiologic-
al links cannot be hypothesized without additional information,
such as department and institution of hospitalization, ASC of resi-
dence and countries they have travelled through before entering
the Netherlands. Due to limited clustering and wide dispersion of
the origin of the asylum seekers carrying the isolates within each
cluster, no conclusion can be drawn regarding the geographical
epidemiology and origin of the isolates.
A limited number of studies have previously sequenced MDROs
in a refugee/asylum seeker patient population.27,28 To our know-
ledge, this is the first study to investigate ESBL-E. coli strains iso-
lated from asylum seekers using WGS on a large scale
documenting various genetic characteristics, such as STs, genotyp-
ic resistance profiles and phylogenetic relatedness. This informa-
tion is still scarce in the related literature and can help to optimize
treatment, hospital hygiene strategies and infection control meas-
ures. Furthermore, our study population exhibited a large variation
in age, number of days in the Netherlands and country of origin,
reflecting the main countries from which migrants originate,
namely Syria, Afghanistan and Iraq.1
Due to the retrospective nature of this study, we did not have
access to important information, such as travelling and antibiotic
consumption history. In addition, information regarding asylum
seeker hospitalization, such as reason for admission, department
of admission, duration of hospitalization and treatment given, was
not available. Furthermore, we had no access to data regarding
the specific ASCs where our study population resided after their ar-
rival in the Netherlands. Close contact within a facility can lead to
transmission of MDROs. In our study, no clear pattern of transmis-
sion was observed.
Conclusions
The most frequently isolated clones in the study are already
detected on a regular basis within the Dutch population. No mcr-
or carbapenemase-producing clones were detected among the
asylum seeker population. No clustering between asylum seekers
and control group strains was observed.
Even though no assumptions can be made on whether trans-
mission within the asylum seeker population occurs or not, small
clustering within the asylum seeker strains could be an indication
of this. Based on the results of this study, there is no clear evidence
as to whether asylum seekers obtained their MDROs in their coun-
try of origin, during their journey to the Netherlands or after their
arrival in the Netherlands. Asylum seekers originating from the
same country showed a large variability in resistance and phylo-
genetic relatedness.
Further research on the genetic characteristics of MDRO isolates
carried by asylum seekers could reveal important information on
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